Eligi
Med
Ensayos clínicos
Suscripción
Sobre EligiMed
Ensayos Clínicos de Hematología | EligiMed
Ensayos clínicos
8.676 ensayos encontrados
Completado
Fase 3
ClinicalTrials.gov
A Phase 3 Randomized, Open-label (Sponsor-blind), Active-controlled, Parallel-group, Multi-center, Event Driven Study in Non-dialysis Subjects With Anemia Associated With Chronic Kidney Disease to Evaluate the Safety and Efficacy of Daprodustat Compared to Darbepoetin Alfa
INTERVENTIONAL
Inicio: 27 de sept de 2016
ID: NCT02876835
Completado
Fase 3
ClinicalTrials.gov
A Phase 3 Randomized, Double-blind, Active-controlled, Parallel-group, Multi-center Study in Hemodialysis Participants With Anemia of Chronic Kidney Disease to Evaluate the Efficacy, Safety and Pharmacokinetics of Three-times Weekly Dosing of Daprodustat Compared to Recombinant Human Erythropoietin, Following a Switch From Recombinant Human Erythropoietin or Its Analogs
INTERVENTIONAL
Inicio: 5 de sept de 2018
ID: NCT03400033
Completado
Fase 3
ClinicalTrials.gov
A Randomized, Global, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy and Safety of Once-daily Oral Avatrombopag for the Treatment of Adults With Thrombocytopenia Associated With Liver Disease Prior to an Elective Procedure
INTERVENTIONAL
Inicio: 1 de feb de 2014
ID: NCT01972529
Completado
ClinicalTrials.gov
An International Multicenter Clustered Randomized Controlled Trial to imProve Treatment With AntiCoagulanTs in Patients With Atrial Fibrillation.
INTERVENTIONAL
Inicio: 1 de jun de 2014
ID: NCT02082548
Completado
Fase 3
ClinicalTrials.gov
A Phase 3, Multicenter, Randomized, Open-Label, Active-Controlled Study of the Efficacy and Safety of FG-4592 in the Treatment of Anemia in Incident-Dialysis Patients
INTERVENTIONAL
Inicio: 11 de feb de 2014
ID: NCT02052310
Completado
Fase 3
ClinicalTrials.gov
Safety and Efficacy of (PN-152,243)/PN-196,444 in the Prevention of Thrombocytopenia in Patients Receiving Myelosuppressive Treatment Regimens Requiring Platelet Transfusion Support.
INTERVENTIONAL
Inicio: 1 de dic de 1999
ID: NCT00037791
Completado
Fase 3
ClinicalTrials.gov
A Randomized, Comparative Study of HEMAX PFS® Versus EPREX/ ERYPO® in the Treatment of Anemia With Epoetin Alfa in Patients With Predialysis Chronic Kidney Disease
INTERVENTIONAL
Inicio: 28 de feb de 2018
ID: NCT04036253
Completado
Fase 3
ClinicalTrials.gov
A Randomised, Double-blind, Parallel Group, Phase 3, Efficacy and Safety Study of Ticagrelor Compared With Clopidogrel for Prevention of Vascular Events in Patients With Non-ST or ST Elevation Acute Coronary Syndromes (ACS) [PLATO- a Study of PLATelet Inhibition and Patient Outcomes]
INTERVENTIONAL
Inicio: 1 de oct de 2006
ID: NCT00391872
Desconocido
ClinicalTrials.gov
Reduced Frequency Hemodialysis in Prevalent Patients Due to the Coronavirus Disease
OBSERVATIONAL
Inicio: 20 de mar de 2020
ID: NCT04374058
Completado
Fase 3
ClinicalTrials.gov
An Open-label Study To Evaluate Prophylaxis Treatment, And To Characterize The Efficacy, Safety, And Pharmacokinetics Of B-domain Deleted Recombinant Factor Viii Albumin Free (Moroctocog Alfa [Af-cc]) In Children With Hemophilia A
INTERVENTIONAL
Inicio: 1 de dic de 2007
ID: NCT00543439
Completado
Fase 3
ClinicalTrials.gov
A 28-week, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multi-center, Study in Recombinant Human Erythropoietin (rhEPO) naïve Non-dialysis Participants With Anemia Associated With Chronic Kidney Disease to Evaluate the Efficacy, Safety and Effects on Quality of Life of Daprodustat Compared to Placebo
INTERVENTIONAL
Inicio: 5 de mar de 2018
ID: NCT03409107
Anterior
1
...
9
10
11
...
434
Siguiente
Filtros